Patents

International Patent Filing (PCT/SG2018/050075) (WO 2018/151681 A1). US Patent Application No: 16/485,973. South Africa Patent Application 2019/06047; Compounds for Treating Tuberculosis; Inventors: G. Grüber, R.W. Bates, A. Hotra, T. Dick, K. Pethe

Singapore “Provisional” Patent (10201807627U); Unravelling the essentials of subunit ε of mycobacterial F-ATP synthases for proper cell growth of the pathogen and novel inhibitors of mycobacterial F-ATP synthases; Inventors: G. Grüber, R.W. Bates, V.K.H. Amaravadhi, P. Ragunathan, W.G. Saw, J. Shin, P. Sae-Lao

Singapore (SG) “Provisional” Patent (Application Number 10202104853U; Identifying The Essentials Of Subunit δ Of Mycobacterial F-ATP Synthases For Proper ATP Synthesis And A Novel Inhibitor Of Mycobacterial F-ATP Synthases; Inventors: G. Grüber, V.K.H. Amaravadhi, W.G. Saw, P. Ragunathan

Singapore (SG) “Provisional” Patent (Application Number 10202203339W); Title: GaMF1.39's Enhanced Antitubercular Activity In Combination With Anti-Tubercular Drugs Targeting The Oxidative Phosphorylation Pathway”; Inventors: G. Grüber, R.W. Bates, S.P. Ng

License agreement with Neuro-Horizon Pharma, LLC, USA signed on the 6th of May 2022; International Patent (PCT/SG2020/050695); Title: Anti-Tubercular Compounds; Inventors: G. Grüber, R.W. Bates, P.S. Ng

Canadian Patent Application (No: 3,163,103) (National Phase Entry from PCT Application No: PCT/SG2020/050695); Title: Compounds For Treating Tuberculosis; Inventors: G. Grüber, R.W. Bates and Ng, S.P.

US Patent Application (No: 17/780,235) (National Phase Entry from PCT Application No: PCT/SG2020/050695); Title: Compounds For Treating Tuberculosis; Inventors: G. Grüber, R.W. Bates and Ng, S.P.

Indian Patent Application (No: 202237034304) (National Phase Entry from PCT Application No: PCT/SG2020/050695); Title: Compounds For Treating Tuberculosis; Inventors: G. Grüber, R.W. Bates and Ng, S.P.

Chinese Patent Application (No: 202080093938.6) (National Phase Entry from PCT Application No: PCT/SG2020/050695); Title: Compounds For Treating Tuberculosis; Inventors: G. Grüber, R.W. Bates and Ng, S.P.; published under CN 115380029 A.

International Patent Filing (PCT/SG2022/050676) (WO 2023/048641 A2). Title: Atomic Insight Into Coupling Subunit ε of Mycobacterium abscessus's F-ATP Synthase And Design Of A Potent Mycobacterium abscessus Growth Inhibitor Targeting The Engine. G. Grüber, J. Shin, V.K.H. Amaravadhi, C.F. Wong, P. Ragunathan

Chinese Patent Application (No: 202280061630.2). Title: Atomic Insight Into Coupling Subunit ε of Mycobacterium abscessus's F-ATP Synthase And Design Of A Potent Mycobacterium abscessus Growth Inhibitor Targeting The Engine. G. Grüber, J. Shin, V.K.H. Amaravadhi, C.F. Wong, P. Ragunathan; published under CN 118043315 A.

European "Provisional" Patent Application (No: 22873290.5). Title: Atomic Insight Into Coupling Subunit ε of Mycobacterium abscessus's F-ATP Synthase And Design Of A Potent Mycobacterium abscessus Growth Inhibitor Targeting The Engine. G. Grüber, J. Shin, V.K.H. Amaravadhi, C.F. Wong, P. Ragunathan

European “Provisional” Patent Application (Application Number 23306555.6). Title: Discovery Of A F-ATP Synthase Inhibitor For The Treatment Of Non-Tuberculous Mycobacteria Diseases; Inventors: G. Grüber, R. W. Bates, P. Ragunathan, P. Sae-Lao, L. Kremer

Singapore “Provisional” Patent Application (Application Number 10202302811R). Title: Inhibitors Of The Cytochrome Bd Oxidase For The Treatment Of Tuberculosis And Other Mycobacterial Diseases; Inventors: K. Pethe, S. Singh, G. Grüber, S. P. Ng

Singapore “Provisional” Patent Application (Application Number 10202400504Y). Title: Discovery Of A F-ATP Synthase To Eradicate Of Non-Tuberculous Mycobacteria Diseases; Date field: 23rd February 2024; Inventors: G. Grüber, R. W. Bates, P. Ragunathan, P. Sae-Lao, A. V. K Harikishore